XPDI Merger Proceeds
Company: Core Scientific
The claim, verbatim
The merger provided gross proceeds of approximately $221.6 million from the XPDI trust account, resulting in approximately $195.0 million in net cash proceeds to Core Scientific after transaction expenses.
Source (primary)
Core Scientific 10-Q filed 2022-08-22 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “The Merger provided gross proceeds of approximately $ 221.6 million from the XPDI trust account, resulting in approximately $ 195.0 million in net cash proceeds to Core Scientific, after the payment of transaction expenses”
How we checked this
Checked on September 22, 2026. The cited source supports every part of this claim.
Both the gross proceeds and net cash proceeds figures appear verbatim in the document.
Confirmed in the source:
- The merger provided gross proceeds of approximately $221.6 million from the XPDI trust account
- The merger resulted in approximately $195.0 million in net cash proceeds to Core Scientific after transaction expenses
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000162828022023382/core-20220630.htm) in full (555,145 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 10-Q filed 2022-08-22
Quote: “The Merger provided gross proceeds of approximately $ 221.6 million from the XPDI trust account, resulting in approximately $ 195.0 million in net cash proceeds to Core Scientific, after the payment of transaction expenses”